Correction to: 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy: Developed by the task force on the management of cardiovascular disease and pregnancy of the European Society of Cardiology (ESC) Endorsed by the European Society of Gynecology (ESG)
Key Points
The aim is to present corrections to the current guidelines for managing cardiovascular disease during pregnancy.
Review of existing guidelines by the task force
Consultation with stakeholders in cardiology and gynecology
Incorporation of new research findings
Clarifications on risk assessment for cardiovascular disease in pregnant individuals
Updates on treatment recommendations and interventions
Enhanced guidelines for monitoring and managing cardiac complications during pregnancy
Correction to: 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy: Developed by the task force on the management of cardiovascular disease and pregnancy of the European Society of Cardiology (ESC) Endorsed by the European Society of Gynecology (ESG) | Synapse